Clinical Trial Update: Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety of topically applied LEO 43204 for actinic keratosis on the face/chest, scalp, and trunk/extremities has completed and safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• LEO 43204

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2019-03-05